Diagnosis

Gastroesophageal reflux disease

Chronic symptoms or mucosal damage incurred by the abnormal reflux of gastric contents into the esophagus and beyond.

Also known as: Acid reflux, GERD

Etiology

Cause/Pathophysiology [iir]

  1. Esophagus: Poor esophageal motility, impaired protective saliva or mucosa

  2. Lower esophageal sphincter: The high resting tone prevents regurgitation

    • Drugs: nitrates, calcium channel blocker agents, and anticholinergics reduces the lower esophageal sphincter pressure --> allows reflux

  3. Diaphragm: Provides extrinsic reinforcement to the lower esophageal sphincter

    • Diaphragmatic hiatus hernia --> lack of reinforcement and compression of stomach

  4. Stomach:

    • Delayed gastric emptying can increase volume and pressure

  5. Intra-abdominal pressure due to obesity, pregnancy, ascites --> GERD

Risk factors [iir]

Complications [iir]

Epidemiology

Prevalence per 100.000 [udq][mpa][4t2][g7z]

Epidemiology chart for Prevalence

Incidence per 100.000 [udq][mpa][4t2][g7z]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Choking, Cough, Dysphagia, Dysphonia, Globus sensation, Heartburn, Hematemesis, Hoarseness, Melena, Nausea, Odynophagia, Postprandial fullness, Regurgitation, Vomiting, Wheezing

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Pain
Radiates
Throat (pharynx and larynx)RetrosternalCollum
Onset
Subacute (hours)Gradual (days)
Pattern
Intermittent
Provoked by
Postprandial
Quality
Burning
Severity
Mild (1-3)Moderate (4-7)

Approach

Classification [iir]

Treatment

  1. Goals: [s6a]

    • Control symptoms

    • Heal and prevent recurrent esophagitis

  2. Lifestyle modifications: [s6a][iir]

    • Weight loss (if overweight)

    • Avoiding alcohol, chocolate, citrus juice, peppermint, coffee, tomato products

    • Avoiding peppermint, coffee, and possibly the onion family

    • Avoid large meals

    • Waiting 3 hours after a meal to lie down

    • Refraining from ingesting food (except liquids) within 3 hours of bedtime

    • Elevating the head of the bed by 8 inches

    • Avoiding bending or stooping positions

  3. Control of gastric acid secretion:

    • Pharmacotherapy

      • H2 receptor antagonists (eg, cimetidine, famotidine, nizatidine)

      • Proton pump inhibitors (eg, omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole) 

      • Potassium-competitive acid blockers (eg, vonoprazan) 

      • Prokinetic agents (eg, metoclopramide)

      • Antacids (eg, aluminum hydroxide, magnesium hydroxide)

    • Surgical treatment: antireflux fundoplication

      • If symptoms that are not completely controlled by PPI

      • Patients who desire definitive, one-time treatment

      • The presence of Barrett esophagus

      • The presence of extraesophageal manifestations

      • Young patients

      • Poor patient compliance with medications

      • Postmenopausal women with osteoporosis

      • Patients with cardiac conduction defects

      • Cost of medical therapy

Differential diagnoses

Achalasia, Acute laryngitis, Asthma, Cholelithiasis, Diabetic gastroparesis, Eosinophilic esophagitis, Esophageal cancer, Esophageal diverticula, Esophageal hiatal hernia, Esophageal perforation, Esophageal spasm, Esophageal stricture, Esophagitis, Gastric cancer, Gastritis, Intestinal malrotation, Irritable bowel syndrome, Lung cancer, Myocardial infarction, Pneumonia, Ulcer disease


References

[1] Azer SA, Goosenberg E. Gastroesophageal Reflux Disease (GERD) [Updated 2025 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554462/

[2] Li N, Yang WL, Cai MH, Chen X, Zhao R, Li MT, Yan XL, Xue LW, Hong L, Tang MY. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of disease study 2019. BMC Public Health. 2023 Mar 29;23(1):582.

[3] Zhang D, Liu S, Li Z, Wang R. Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study. Ann Med. 2022 Dec;54(1):1372-1384.

[4] GBD 2017 Gastro-oesophageal Reflux Disease Collaborators. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):561-581.

[5] Wang, Kun; Zhang, Li; He, Zhong-Hu; Liu, Zuo-Jing; Zhang, Lu; Hu, Nan; Jin, Zhu; Ke, Yang; Duan, Li-Ping. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chinese Medical Journal 132(13):p 1516-1523, July 5, 2019.

[6] http://emedicine.medscape.com/article/176595 (2014-01-02); [Medscape]

Scroll to top